How social experiences affect immune cells
Part of Immune system & allergy clinical trials.
This study looks at how social experiences and background may influence immune cell activity. It could help understand why some groups have different health outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You identify as non-Hispanic Black, non-Hispanic White, or Hispanic.
- You live within 25 miles of, work at, or attend Morgan State University, the University of Baltimore, or Texas Christian University.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for and tracks nervous system problems in people with immune system disorders. It aims to better understand how infections or inflammation affect the brain and nerves in these patients.
This study looks at how the immune system works in people who have—or might have—an increased risk of infections. It also enrolls their healthy blood relatives so researchers can compare immune features; results may help doctors understand who is at higher risk and why.
This study looks for genetic causes of immune problems, such as unusually frequent infections, abnormal allergies, or autoimmune or inflammation conditions. It may help by improving how doctors understand these disorders and by matching families with possible genetic diagnoses.
This study looks at how your body’s immune system reacts in different tissues by collecting and storing samples for research. You might be able to join if you’re an adult and can consent, and if you don’t have certain bleeding risks that could make sample collection unsafe.
This study evaluates and follows patients with inflammatory conditions related to immune system problems. It aims to understand these disorders better and may offer opportunities to participate in other research.
This study looks at how the body's immune system reacted to COVID-19 in people who had either severe or mild cases. The goal is to learn more about a specific part of the immune response (called IFN-I) to better understand the disease.
Hear when a new Inflammatory Response trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.